CN117106678A - Enrichment culture of marine organism film bacteria and method for obtaining genome thereof - Google Patents
Enrichment culture of marine organism film bacteria and method for obtaining genome thereof Download PDFInfo
- Publication number
- CN117106678A CN117106678A CN202311376480.7A CN202311376480A CN117106678A CN 117106678 A CN117106678 A CN 117106678A CN 202311376480 A CN202311376480 A CN 202311376480A CN 117106678 A CN117106678 A CN 117106678A
- Authority
- CN
- China
- Prior art keywords
- culture
- acid
- biofilm
- marine
- enrichment culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 23
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 41
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 40
- 230000001580 bacterial effect Effects 0.000 claims abstract description 31
- 239000001963 growth medium Substances 0.000 claims abstract description 22
- 238000012163 sequencing technique Methods 0.000 claims abstract description 20
- 238000012136 culture method Methods 0.000 claims abstract description 15
- 238000012258 culturing Methods 0.000 claims abstract description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 241001052560 Thallis Species 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 239000013535 sea water Substances 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000005070 sampling Methods 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- 238000007400 DNA extraction Methods 0.000 claims description 4
- 239000007995 HEPES buffer Substances 0.000 claims description 4
- 238000007672 fourth generation sequencing Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000013507 mapping Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N L-glucitol Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 3
- 229940024606 amino acid Drugs 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 claims 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 claims 1
- 229940015975 1,2-hexanediol Drugs 0.000 claims 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims 1
- 229940035437 1,3-propanediol Drugs 0.000 claims 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical compound OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 claims 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims 1
- 229930195711 D-Serine Natural products 0.000 claims 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims 1
- 229930182846 D-asparagine Natural products 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims 1
- 229930182847 D-glutamic acid Natural products 0.000 claims 1
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 claims 1
- 229930195715 D-glutamine Natural products 0.000 claims 1
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 claims 1
- 229930195721 D-histidine Natural products 0.000 claims 1
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims 1
- 229930182832 D-phenylalanine Natural products 0.000 claims 1
- 229930182827 D-tryptophan Natural products 0.000 claims 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims 1
- OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 claims 1
- 229930195709 D-tyrosine Natural products 0.000 claims 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
- 229920001202 Inulin Polymers 0.000 claims 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-Glutamic acid Natural products OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- HEBKCHPVOIAQTA-IMJSIDKUSA-N L-arabinitol Chemical compound OC[C@H](O)C(O)[C@@H](O)CO HEBKCHPVOIAQTA-IMJSIDKUSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 claims 1
- 239000004395 L-leucine Substances 0.000 claims 1
- 235000019454 L-leucine Nutrition 0.000 claims 1
- WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- 229930195722 L-methionine Natural products 0.000 claims 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 claims 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 1
- 108010077895 Sarcosine Proteins 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 229960003767 alanine Drugs 0.000 claims 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 claims 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- 229940107161 cholesterol Drugs 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims 1
- 229950006191 gluconic acid Drugs 0.000 claims 1
- 235000012208 gluconic acid Nutrition 0.000 claims 1
- 229940097043 glucuronic acid Drugs 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 claims 1
- 229960004275 glycolic acid Drugs 0.000 claims 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims 1
- 229960002885 histidine Drugs 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 1
- 229940029339 inulin Drugs 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 229960003136 leucine Drugs 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 229960004452 methionine Drugs 0.000 claims 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims 1
- 229940107700 pyruvic acid Drugs 0.000 claims 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 1
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 claims 1
- 229940043230 sarcosine Drugs 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 229960001153 serine Drugs 0.000 claims 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims 1
- 235000010356 sorbitol Nutrition 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- 229960002898 threonine Drugs 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 229960004441 tyrosine Drugs 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 12
- 244000005700 microbiome Species 0.000 abstract description 5
- 238000001514 detection method Methods 0.000 abstract description 2
- 238000011162 downstream development Methods 0.000 abstract 1
- 239000000306 component Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000011435 rock Substances 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000001712 DNA sequencing Methods 0.000 description 3
- 239000012237 artificial material Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001453382 Nitrosomonadales Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/20—Sequence assembly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of marine microorganism detection, and particularly relates to enrichment culture of marine biofilm bacteria and a genome acquisition method thereof. The invention establishes a new culture medium formula for enrichment culture of marine microorganisms, comprises non-carbon source components and 69 selected effective carbon sources, and designs culture conditions and metagenome sequencing schemes, thereby successfully culturing marine biofilm flora in a laboratory or obtaining 535 bacterial genomes with high integrity. The method can efficiently culture and obtain the microbial community with complex and stable structure from a plurality of doors and the bacterial genome with higher abundance in the community, thereby providing basis and guidance for further downstream development of microbial resources and improvement of culture methods.
Description
Technical Field
The invention belongs to the technical field of marine microorganism detection, and particularly relates to enrichment culture of marine biofilm bacteria and a genome acquisition method thereof.
Background
The current bacterial culture method is generally suitable for bacteria with specific metabolic capability, such as ammonia oxidizing bacteria, phosphate solubilizing bacteria and the like, has narrower coverage and poor universality, and cannot realize broad-spectrum culture of various bacteria in complex communities. The reasons for this technical problem are mainly the following three aspects: 1) The enrichment medium has single carbon source, for example, glucose is only used as the carbon source, and the complex and various carbon source types in the environment cannot be represented; 2) No or only a single trace element is added, which is not beneficial to the culture of bacteria with higher requirement on trace elements; 3) The influence of culture condition factors such as pH fluctuation on the growth of microorganisms is not considered except nutrient factors of the culture medium.
In addition, the current bacterial culture method does not have a method for acquiring genome information after corresponding enrichment, and the acquired genome information is incomplete. The reasons are as follows: on the one hand, the current bacterial culture method is established before the popularization and application of the third-generation DNA sequencing, and the second-generation DNA sequencing is directly carried out, and long contigs cannot be obtained due to the short reading length, so that high-quality genomes (MAGs) with high integrity and low pollution degree cannot be obtained; on the other hand, due to the limitations of bioinformatics technology, the prior art is built without software to achieve mixed assembly of second and third generation DNA sequences.
Disclosure of Invention
In order to solve the technical problems, the invention provides an enrichment culture method of marine biofilm bacteria and a genome acquisition method thereof, which can efficiently culture to obtain a microbial community with a complex and stable structure and obtain a high-quality bacterial genome of the community.
The invention is realized by the following technical scheme:
the enrichment culture method of the marine organism film bacteria comprises the following steps:
(1) Sampling: and collecting a marine biofilm sample.
Preferably, the marine biofilm sample is from a rock surface submerged in seawater, preferably in a marine area where human activity has a low impact.
(2) Sample treatment: centrifuging the collected sample to remove supernatant to obtain bacterial precipitate, washing the bacterial precipitate, re-suspending in sterile seawater, filtering to obtain biofilm bacterial cells, standing and preserving.
Preferably, the centrifugal speed is 5000-6000rpm, and the time is 5-6min;
the purpose of washing the bacterial precipitate is to remove carbon source nutrition, and the washing liquid is PBS;
the sterile sea water is prepared by dissolving artificial sea salt in ultrapure water for sterilization, wherein the addition amount of the artificial sea salt is 30g/L;
the filtration adopts a 3 mu m cellulose ester membrane filter, and can filter fungi, algae and other particles;
the standing preservation temperature is 2-8 ℃ and the time is 14-18h, so as to consume the residual carbon source nutrition.
(3) Preparing a culture medium: the culture medium comprises carbon source substances and non-carbon source substances, the types and the addition amounts of the non-carbon source substances are shown in table 1, the types of the carbon source substances are any one of substances in table 2, and the addition amount is 1g/L, so that 69 culture mediums corresponding to 69 carbon source substances in table 2 are respectively prepared.
Preferably, the pH of the medium is 6.5-7.5;
the culture medium also comprises HEPES, and the addition amount is 1mol/L, so as to stabilize the pH value in the growth process of the microbial community.
Non-carbon source substances in the medium described in Table 1
Carbon source substances in the Medium described in Table 2
(4) Enrichment culture: inoculating the biofilm bacterial cells obtained in the step (2) into the culture mediums prepared in the step (3), wherein each culture medium is provided with two culture conditions of oxygen culture and anaerobic culture, standing and culturing under dark conditions until biofilm is formed, collecting biofilm bacterial cells, freezing with liquid nitrogen, and storing for subsequent DNA extraction.
Preferably, the culture temperature is 25-26 ℃, the culture time is 20-30 days, and the bacterial density OD is collected when the biofilm bacteria are collected 600 0.8-1.2, and the preservation temperature of the thalli is less than or equal to-80 ℃;
the gas environment of aerobic culture is 80% of nitrogen and 20% of oxygen, and the gas environment of anaerobic culture is nitrogen;
the nitrogen is high-purity nitrogen with the purity of 99.999 percent.
The acquisition method of the marine organism membranous bacteria genome is realized by metagenome sequencing and metagene component box technology, and specifically comprises the following steps:
s1, sequencing the collected biofilm thalli by an Illumina sequencing technology, obtaining 138 samples, respectively obtaining 20G data amount by each sample, and obtaining MAGs by sequencing data through a binning software Maxbin (v2.2.6);
s2, dividing MAGs with the integrity of more than 80% and the pollution of more than 5% obtained in the step S1 into boxes by using Metabat (v0.32.5);
s3, further separating MAGs with the integrity of more than 80% and the pollution of more than 5% obtained in the step S2 into boxes by using Concoct (v1.1.0);
s4, respectively mixing the biological film thalli cultured by four carbon sources of alcohol, amino acid, organic acid and sugar in the table 2 into 4 samples, carrying out Nanopore sequencing, and reassembling the long-reading long sequence obtained by sequencing and MAGs with the integrity of more than 80% and the pollution of less than 5% obtained by the steps S1, S2 and S3 in a box, thereby obtaining the high-quality non-redundant MAGs with the integrity of more than 90% and the pollution of less than 5%.
The recombinant assembly in step S4 specifically includes the steps of:
s41, constructing an original MAG as an index, mapping an Illumina sequence to the original MAG index by using Bowtie2, and extracting a matched sequence by using Samtools (v 1.11);
s42, performing BLASTN search on the Nanopore data aiming at the original MAG, and reserving a matching sequence with more than 99% of identity;
s43, in the single genome mode, the Illumina and Nanopore sequences on a given MAG match are cross-assembled using software SPades (v3.12.0).
The high quality non-redundant MAGs have an average nucleotide similarity (ANI, average nucleotide identity) of less than 99%.
Genome quality was detected by software CheckM (v1.1.2).
Compared with the prior art, the invention has the following beneficial effects:
1. the culture medium formula disclosed by the invention contains a plurality of dissolved organic carbon and a plurality of vitamin components which are abundantly existing in the marine water body, and meanwhile, a pH buffer solution is used. Through testing the culture capacity of more than 100 carbon sources, the finally available biomass is used as an index, and 69 carbon sources are finally obtained as unique carbon sources to perform enrichment culture on the biofilm community. These carbon sources can be divided into four groups according to their chemical nature: alcohols, amino acids, organic acids and carbohydrates, the use of these carbon sources enables efficient diversion of bacterial genomes in the metagenome at different carbon sources. The invention uses multiple vitamin components, while other culture medium components, such as nitrogen source, have simple components and can eliminate other unnecessary component influences. In addition, HEPES buffer solution is added into the culture medium, and the buffer system has a good effect of stabilizing the fluctuation of pH in the enrichment culture process.
2. According to the invention, two culture conditions of oxygen and anaerobic are correspondingly arranged on each culture medium of the carbon source, and the microbial community obtained by culture under each oxygen condition is independently subjected to secondary metagenomic sequencing, so that the obtained file is very beneficial to the subsequent two-dimensional metagenomic component boxes. In addition, after the microbial community samples enriched and cultured by the same type of carbon source culture medium are combined, the third-generation DNA sequencing is performed, a long-reading long sequence is obtained, and the integration of the second-generation and third-generation data is obviously improved for the genome integrity in the box separation process.
Drawings
FIG. 1, a technical roadmap of the invention;
FIG. 2, a structure of a phylum/class horizontal microbial community enriched in culture according to the present invention, in which the bacteria are ranked according to the top 30 of abundance, and the bacteria not at the top 30 are others;
FIG. 3, distribution of gate/line level numbers of 535 high quality genomes assembled after enrichment culture according to the invention.
Detailed Description
The invention is further described below in connection with examples, all materials used in the examples and comparative examples being commercially available, except as specifically indicated.
Example 1
The enrichment culture method of the marine organism film bacteria comprises the following steps:
(1) Sampling: collecting a marine organism film sample;
collecting a marine biofilm sample in an intertidal zone of a Qingdao wheat island sea area, wherein the sampling point is positioned at a position leading to open sea, and the influence of human activities is low; at the time of collection, a biofilm was scraped from the rock surface immersed in seawater with a sterile cotton swab and the collected sample was immediately transferred to the laboratory.
(2) Sample treatment: centrifuging the collected sample to remove supernatant to obtain bacterial precipitate, washing the bacterial precipitate, re-suspending in sterile seawater, filtering to obtain biofilm bacterial cells, standing and preserving;
the centrifugal speed is 6000rpm, and the time is 5min;
the purpose of washing the bacterial precipitate is to remove carbon source nutrition, and the washing liquid is PBS;
the sterile sea water is prepared by dissolving artificial sea salt in ultrapure water for sterilization, wherein the addition amount of the artificial sea salt is 30g/L;
the filtration adopts a 3 mu m cellulose ester membrane filter, and can filter fungi, algae and other particles;
the standing preservation temperature is 4 ℃ and the time is 16 hours, so as to consume the rest carbon source nutrition.
(3) Preparing a culture medium: the culture medium comprises carbon source substances and non-carbon source substances, the types and the addition amounts of the non-carbon source substances are shown in table 1, the types of the carbon source substances are any one of substances in table 3, and the addition amount is 1g/L, so that 69 culture mediums corresponding to 69 carbon source substances in table 3 are respectively prepared;
the pH of the culture medium is 6.5-7.5;
the culture medium also comprises HEPES, and the addition amount is 1mol/L, so as to stabilize the pH value in the growth process of the microbial community.
Carbon source substances and numbers in the medium shown in Table 3
(4) Enrichment culture: respectively inoculating the biofilm bacterial cells obtained in the step (2) into the culture mediums prepared in the step (3), wherein each culture medium is provided with two culture conditions of oxygen culture and anaerobic culture, standing and culturing under dark conditions until a biofilm is formed, collecting biofilm bacterial cells, freezing with liquid nitrogen, and storing for subsequent DNA extraction;
the culture temperature is 25 ℃, the culture time is 25 days, and the bacterial density OD when the biofilm bacterial cells are collected 600 1.0, and storage temperature of-80 ℃;
the gas environment of aerobic culture is 80% of nitrogen and 20% of oxygen, and the gas environment of anaerobic culture is nitrogen; the nitrogen is high-purity nitrogen with the purity of 99.999 percent.
The acquisition method of the marine organism membranous bacteria genome is realized by metagenome sequencing and metagene component box technology, and specifically comprises the following steps:
s1, sequencing the collected biofilm thalli by an Illumina sequencing technology, obtaining 138 samples, respectively obtaining 20G data amount by each sample, and obtaining MAGs by sequencing data through a binning software Maxbin (v2.2.6);
s2, dividing MAGs with the integrity of more than 80% and the pollution of more than 5% obtained in the step S1 into boxes by using Metabat (v0.32.5);
s3, further separating MAGs with the integrity of more than 80% and the pollution of more than 5% obtained in the step S2 into boxes by using Concoct (v1.1.0);
s4, respectively mixing the biological film thalli cultured by four carbon sources of alcohol, amino acid, organic acid and sugar in the table 2 into 4 samples, carrying out Nanopore sequencing, and reassembling the long-reading long sequence obtained by sequencing and MAGs with the integrity of more than 80% and the pollution of less than 5% obtained by the steps S1, S2 and S3 in a box, thereby obtaining the high-quality non-redundant MAGs with the integrity of more than 90% and the pollution of less than 5%.
The recombinant assembly in step S4 specifically includes the steps of:
s41, constructing an original MAG as an index, mapping an Illumina sequence to the original MAG index by using Bowtie2, and extracting a matched sequence by using Samtools (v 1.11);
s42, performing BLASTN search on the Nanopore data aiming at the original MAG, and reserving a matching sequence with more than 99% of identity;
s43, in the single genome mode, the Illumina and Nanopore sequences on a given MAG match are cross-assembled using software SPades (v3.12.0).
The high quality non-redundant MAGs have an average nucleotide similarity (ANI, average nucleotide identity) of less than 99%.
Genome quality was checked by software CheckM (v1.1.2), and the data analysis described above was performed on the linux system installed in this experiment.
By the method of the present invention (FIG. 1), a structurally complex, stable microbial community is cultivated, which is composed of microorganisms from a plurality of doors, as shown in FIG. 2 (corresponding data of FIG. 2 are shown in Table 4 and Table 5, wherein suffix-1 represents an aerobic cultivated sample, suffix-2 represents an anaerobic cultivated sample), and which can be preserved in glycerol tubes for a long period of time for resuscitative and cultivation. By the method of the invention we obtained 535 high quality (integrity >90%, potential contamination <5%, below) genomes of bacteria (FIG. 3). Analysis showed that these genomes were distributed in 13 different bacterial phylum, 68 different bacterial families, 156 different bacterial genera, with higher diversity. The acquisition of these genomes has a positive effect on the subsequent analysis of the development of the responding bacteria, the mining of their valuable metabolites.
TABLE 4 door/class level top 30 microbial community abundance table for aerobic culture
TABLE 5 door/class level top 30 microbial community abundance table for anaerobic enrichment culture
/>
/>
/>
Comparative example 1
Comparative example 1 enrichment culture of marine biofilm bacteria and genome acquisition were performed by conventional methods, as follows:
(1) Sampling: collecting biofilm growing on rock and artificial material plates (artificial material plates are placed for 12-30 days) in offshore areas of three oceans (Pacific, indian, atlantic), obtaining 101 biofilm samples in total, storing the biofilm samples in ice cubes and rapidly transferring to a laboratory, and storing at-80 ℃;
(2) DNA extraction and sequencing: the DNA of the biofilm was extracted (Qiagen kit, germany) and Illumina sequencing was performed, 115±39 million sequences per biofilm metagenome;
(3) Metagene component box: the contigs (contigs) after metagenomic data assembly (software MEGAHIT, v 1.0.2) were subjected to binning analysis. The first step uses Bowtie2 to map individual metagenome reads to corresponding contigs to generate coverage profiles to reflect the abundance of each contig in the original metagenome; subsequently, the contigs were separated into different genomes by MaxBin2 (v 2.0) using the maximum Expectation-Maximization (EM) with probability (minimum probability of 0.8); the obtained sequences were then further binned with Metabat (v0.24.1) and finally mass-detected for the MAG obtained using CheckM (v0.9.4).
By the method, a high-quality genome of 51 strains of bacteria is finally obtained.
In comparative example 1, there were 101 biofilm samples in total, and the total number of MAGs obtained was 479, of which the number of high-quality MAGs was only 51; in example 1, there were 138 biofilm samples in total, 535 MAG's were counted, and the gate levels and mass results corresponding to the genomes obtained in example 1 and comparative example 1 are shown in Table 6. In the cultivation method, comparative example 1 the present invention example 1 adopts a method of enriching and cultivating a biofilm with a unique carbon source by collecting a biofilm on an artificial material plate and an intertidal zone rock; in the genome acquisition method, comparative example 1 only performs Illumina sequencing to acquire metagenome data, and in the invention, in example 1, a Nanopore sequencing technology is adopted, and genome quality is improved by recombining Illumina and Nanopore results.
In summary, the method for enriching the biofilm by the carbon source and the recombinant assembly method combining the two sequencing technologies of Illumina and Nanopore can obtain enough genomes with high quality in a small amount of biofilm samples, and can provide more high-value information for later analysis of microbial genomes.
TABLE 6 Gate level and quality results for genomes obtained in example 1 and comparative example 1
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
Claims (9)
1. An enrichment culture method of marine biofilm bacteria is characterized by comprising the following steps: the method comprises the following steps:
(1) Sampling: collecting a marine organism film sample;
(2) Sample treatment: centrifuging the collected sample to remove supernatant to obtain bacterial precipitate, washing the bacterial precipitate, re-suspending in sterile seawater, filtering to obtain biofilm bacterial cells, standing and preserving;
(3) Preparing a culture medium: the culture medium comprises carbon source substances and non-carbon source substances;
the types and the addition amounts of non-carbon source substances in the culture medium are as follows: mgSO (MgSO) 4 0.489g/L、NH 4 Cl 0.25g/L、CaCl 2 0.1g/L、KNO 3 1g/L、KH 2 PO 4 0.272g/L、Na 2 HPO 4 0.284g/L、FeCl 3 0.004g/L、H 3 BO 3 0.0286g/L、MnCl 2 ·4H 2 O 0.0181g/L、ZnSO 4 ·7H 2 O 0.0222g/L、Na 2 MoO 4 ·2H 2 O 0.00039g/L、CuSO 4 ·5H 2 O 0.00079g/L;
The carbon source substance in the culture medium is any one of alcohol, amino acid, organic acid and sugar, and the addition amount is 1g/L, wherein the alcohol is any one of salicyl alcohol, dulcitol, D-mannitol, 1, 3-propanediol, erythritol, cholesterol, xylitol, maltitol, 1, 2-hexanediol, L-arabitol, L-sorbitol, ethanol, glycerol, amyl alcohol, inositol, D-arabitol and D-sorbitol; the amino acid is any one of L-tyrosine, D-tyrosine, L-cysteine, L-alanine, D-alanine, L-glutamic acid, D-glutamic acid, L-tryptophan, D-tryptophan, L-serine, D-serine, L-leucine, D-asparagine, D-glutamine, L-histidine, D-histidine, L-methionine, L-phenylalanine, D-phenylalanine, L-threonine and sarcosine; the organic acid is any one of acetic acid, octanoic acid, fumaric acid, D-malic acid, alpha-ketoglutaric acid, lactic acid, taurine, glyoxylic acid, glycolic acid, D-gluconic acid, glucuronic acid, pyruvic acid, oxaloacetic acid, citric acid and acrylic acid; the sugar is any one of L-glucose, L-fucose, D-arabinose, L-mannose, D-raffinose, D-xylose, L-galactose, D-fructose, L-rhamnose, inulin, soluble starch and hyaluronic acid;
69 culture mediums corresponding to 69 carbon source substances are prepared respectively;
(4) Enrichment culture: inoculating the biofilm bacterial cells obtained in the step (2) into the culture mediums prepared in the step (3), wherein each culture medium is provided with two culture conditions of oxygen culture and anaerobic culture, standing and culturing under dark conditions until biofilm is formed, collecting biofilm bacterial cells, freezing with liquid nitrogen, and storing for subsequent DNA extraction.
2. The enrichment culture method of marine biofilm bacteria according to claim 1, wherein: in the step (2), a 3 μm cellulose ester membrane filter was used for filtration.
3. The enrichment culture method of marine biofilm bacteria according to claim 1, wherein: in the step (2), the standing preservation temperature is 2-8 ℃ and the time is 14-18h.
4. The enrichment culture method of marine biofilm bacteria according to claim 1, wherein: in step (3), the pH of the medium is 6.5-7.5.
5. The enrichment culture method of marine biofilm bacteria according to claim 1, wherein: in the step (3), the culture medium further comprises HEPES, and the adding amount is 1mol/L.
6. The enrichment culture method of marine biofilm bacteria according to claim 1, wherein: in the step (4), the culture temperature is 25-26 ℃ and the culture time is 20-30 days.
7. The enrichment culture method of marine biofilm bacteria according to claim 1, wherein: in the step (4), the bacterial density OD at the time of collecting the biofilm cells 600 0.8-1.2.
8. A method for obtaining a genome of marine biofilm bacteria obtained by the enrichment culture method according to any of claims 1 to 7, characterized in that: the method comprises the following steps:
s1, sequencing the collected biofilm thalli by an Illumina sequencing technology, obtaining 138 samples, respectively obtaining 20G data amount by each sample, and obtaining MAGs from sequencing data by a binning software Maxbin;
s2, dividing MAGs with the integrity of more than 80% and the pollution of more than 5% obtained in the step S1 into boxes by using Metabat;
s3, further separating MAGs with the integrity of more than 80% and the pollution of more than 5% obtained in the step S2 into boxes by using a Conct;
s4, respectively mixing the biological film thalli cultured by four carbon sources of alcohol, amino acid, organic acid and sugar in the table 2 into 4 samples, carrying out Nanopore sequencing, and reassembling the long-reading long sequence obtained by sequencing and MAGs with the integrity of more than 80% and the pollution of less than 5% obtained by the steps S1, S2 and S3 in a box, thereby obtaining the high-quality non-redundant MAGs with the integrity of more than 90% and the pollution of less than 5%.
9. The method for obtaining a genome of marine biofilm bacteria according to claim 8, wherein: the recombinant assembly in step S4 specifically includes the steps of:
s41, constructing an original MAG as an index, mapping an Illumina sequence to the original MAG index by using Bowtie2, and extracting a matched sequence by using Samtools;
s42, performing BLASTN search on the Nanopore data aiming at the original MAG, and reserving a matching sequence with more than 99% of identity;
s43, in a single genome mode, using software SPades to cross-assemble the Illumina and Nanopore sequences on a given MAG match.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311376480.7A CN117106678A (en) | 2023-10-24 | 2023-10-24 | Enrichment culture of marine organism film bacteria and method for obtaining genome thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311376480.7A CN117106678A (en) | 2023-10-24 | 2023-10-24 | Enrichment culture of marine organism film bacteria and method for obtaining genome thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117106678A true CN117106678A (en) | 2023-11-24 |
Family
ID=88811383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311376480.7A Pending CN117106678A (en) | 2023-10-24 | 2023-10-24 | Enrichment culture of marine organism film bacteria and method for obtaining genome thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117106678A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101864386A (en) * | 2010-05-14 | 2010-10-20 | 东华大学 | Method for enriching seawater bacteria by asepsis cellulose filter membrane |
US20120052528A1 (en) * | 2009-02-25 | 2012-03-01 | The University Of Tokyo | Method for producing selective medium and use thereof |
CN105950472A (en) * | 2016-07-12 | 2016-09-21 | 中国海洋大学 | High-throughput microorganism isolation culture method |
US20190241943A1 (en) * | 2018-02-08 | 2019-08-08 | Duke University | Rapid phenotyping and identification of microbes from a complex microbial community |
CN112786102A (en) * | 2021-01-25 | 2021-05-11 | 北京大学 | Method for accurately identifying unknown microbial community in water body based on metagenomic analysis |
-
2023
- 2023-10-24 CN CN202311376480.7A patent/CN117106678A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120052528A1 (en) * | 2009-02-25 | 2012-03-01 | The University Of Tokyo | Method for producing selective medium and use thereof |
CN101864386A (en) * | 2010-05-14 | 2010-10-20 | 东华大学 | Method for enriching seawater bacteria by asepsis cellulose filter membrane |
CN105950472A (en) * | 2016-07-12 | 2016-09-21 | 中国海洋大学 | High-throughput microorganism isolation culture method |
US20190241943A1 (en) * | 2018-02-08 | 2019-08-08 | Duke University | Rapid phenotyping and identification of microbes from a complex microbial community |
CN112786102A (en) * | 2021-01-25 | 2021-05-11 | 北京大学 | Method for accurately identifying unknown microbial community in water body based on metagenomic analysis |
Non-Patent Citations (5)
Title |
---|
HANS K. CARLSON ET AL.: "Selective carbon sources influence the end products of microbialnitrate respiration", 《THE ISME JOURNAL》, vol. 14, pages 2036 * |
LIANWEI YE ET AL.: "High-Resolution Metagenomics of Human Gut Microbiota Generated by Nanopore and Illumina Hybrid Metagenome Assembly", 《FRONTIERS IN MICROBIOLOGY》, vol. 13, pages 4 - 5 * |
THEODORE M. FLYNN ET AL.: "Parallelized, Aerobic, Single Carbon-Source Enrichments from Different Natural Environments Contain Divergent Microbial Communities", 《FRONTIERS IN MICROBIOLOGY 》, vol. 8, pages 1 - 14 * |
YU XIA ET AL.: "Strategies and tools in illumina and nanopore-integrated metagenomic analysis of microbiome data", 《METAGENOME》, vol. 2, no. 1, pages 1 - 18 * |
姬博纹: "细菌高通量分类鉴定新方法及在海洋新菌发现中的应用", 《中国优秀硕士学位论文全文数据库 基础科学辑》, no. 2, pages 12 - 17 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Geissinger et al. | The ultramicrobacterium “Elusimicrobium minutum” gen. nov., sp. nov., the first cultivated representative of the termite group 1 phylum | |
CN107287125B (en) | Method for culturing chlorella pyrenoidosa | |
Rago et al. | Bioelectrochemical nitrogen fixation (e-BNF): electro-stimulation of enriched biofilm communities drives autotrophic nitrogen and carbon fixation | |
CN110511882A (en) | A kind of salt tolerant and the bacterial strain with electricity production characteristic and its application in microbiological fuel cell | |
Azizi et al. | Comparison of microbial communities during the anaerobic digestion of Gracilaria under mesophilic and thermophilic conditions | |
CN114703095B (en) | Pseudomonas adulthood and application thereof in field of sewage and wastewater purification | |
CN110791462B (en) | Bacillus subtilis and application thereof in fermentation production of adenosine | |
BR102012012377A2 (en) | Microalgae, and methods for glucose production and for the production of an objectified substance | |
CN113913348B (en) | Klebsiella grignard SA34 and application thereof | |
Srinivas et al. | Rhodovulum imhoffii sp. nov. | |
CN117106678A (en) | Enrichment culture of marine organism film bacteria and method for obtaining genome thereof | |
WO2022262874A1 (en) | Burkholderia sp. and method for producing fr901464 by fermentation thereof | |
Ueda et al. | Lessons from studies of Symbiobacterium thermophilum, a unique syntrophic bacterium | |
CN111378592A (en) | Bacillus licheniformis and method for treating malodorous organic wastewater by using same to purify water | |
CN116162561A (en) | Strain with low temperature resistance and aerobic denitrification functions and application thereof | |
CN101649344A (en) | Biological preparation technology of D-lactamine | |
CN107760627B (en) | Acidum ukemanense for degrading ammonia nitrogen and application thereof | |
CN111793593A (en) | Method for promoting growth of photosynthetic bacteria | |
CN104277996A (en) | Microbacterium keratanolyticum, and culture method and application thereof | |
JP3396786B2 (en) | Culture method of denitrifying bacteria, immobilized denitrifying bacteria and denitrification method using the same | |
KR20160104377A (en) | Biogas production method and biogas produced therefrom | |
CN114854810B (en) | Method for improving yield of antibacterial lipopeptide bacilomycin D through fatty acid metabolism regulation | |
CN109735472A (en) | It is a kind of to produce electricity molten algae marine bacteria and its application | |
CN112011489B (en) | Method for enriching and separating Francisella and/or its neighboring group species, culture medium and preparation method of culture medium | |
US20240200020A1 (en) | Shewanella decolorationis producing tetrodotoxin and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |